Publication Name	World Journal of Clinical Oncology
Manuscript ID	8443
Country	Greece

Received	2013-12-28 14:26
Peer-Review Started	2013-12-28 18:50
To Make the First Decision	2014-02-27 10:57
Return for Revision	2014-03-04 20:52
Revised	2014-03-10 22:02
Second Decision	2014-06-03 16:14
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-03 16:29
Articles in Press	2014-06-03 16:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-18 10:15
Publish the Manuscript Online	2014-08-01 15:17

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen
Manuscript Source	Invited Manuscript
All Author List	Christos Markopoulos, Stylianos Kykalos and Dimitrios Mantas
Funding Agency and Grant Number
Corresponding Author	Christos Markopoulos, MD, Professor of Surgery, Breast Unit, 2nd Propedeutic Department of Surgery, Faculty of Medicine, National and Kapodistrian University of Athens, 8, Iassiou street, 11521 Athens, Greece. cmarkop@hol.gr
Key Words	CYP2D6; Tamoxifen; Breast cancer; Adjuvant treatment
Core Tip	Currently, routine cytochrome P450 (CYP)2D6 testing among women with breast cancer is not recommended and the significance of CYP2D6 phenotype in decision making regarding the administration of tamoxifen is unclear. The present study summarizes current literature regarding clinical studies on CYP2D6*4, particularly in terms of response to tamoxifen therapy and breast cancer outcome.
Publish Date	2014-08-01 15:17
Citation	KMarkopoulos C, Kykalos S, Mantas D. Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen. World J Clin Oncol 2014; 5(3): 374-381
URL	http://www.wjgnet.com/2218-4333/full/v5/i3/374.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i3.374

Full Article (PDF)	WJCO-5-374.pdf
Full Article (Word)	WJCO-5-374.doc
Manuscript File	8443-Review.doc
Answering Reviewers	8443-Answering reviewers.pdf
Copyright License Agreement	8443-Copyright assignment.pdf
Peer-review Report	8443-Peer review(s).pdf
Scientific Misconduct Check	8443-CorssCheck.jpg
Scientific Editor Work List	8443-Scientific editor work list.pdf